Is This Latecomer a Better Buy Than Moderna and Pfizer?

Is This Latecomer a Better Buy Than Moderna and Pfizer?
·4 min read

Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) dominate the coronavirus vaccine market. Johnson & Johnson also sells a coronavirus vaccine. The U.S. awarded the biotech $1.6 billion in funding in the early days of the vaccine race -- and a contract for the delivery of 100 million vaccine doses.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting